IVVD: Invivyd Inc

IVVD Nouvelles

• Investing 11:13 Invivyd forms research group to study monoclonal antibodies for Long COVID
• Investing 11:42 H.C. Wainwright maintains buy rating on Invivyd stock after positive data
• Investing 11:15 Invivyd’s COVID-19 antibody shows promising safety profile in trial
• Investing 11:45 Invivyd stock target cut to $5 by H.C. Wainwright, retains Buy rating
• Investing 11:12 Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA ® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Po
• Investing 11:08 Invivyd’s antibody gains spot in cancer guidelines for COVID-19 PrEP
• Investing 13:40 Invivyd Commends FDA Focus on Contemporary Evidence In Evaluating Medical Interventions To Prevent COVID-19
• Investing 16:14 Invivyd at H.C. Wainwright Conference: Strategic Moves in Antibodies
• Investing 14:14 Invivyd earnings missed by $0.12, revenue fell short of estimates
• Investing 11:15 Invivyd Q1 2025 slides: Revenue grows amid regulatory hurdles and cash concerns
• Benzinga 13:58 What's Going On With Invivyd Stock On Monday? - Invivyd (NASDAQ:IVVD)
• Benzinga 14:20 FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients - Invivyd (NASDAQ:IVVD)